Neutrophilic drug eruptions

Clinics in Dermatology

Volumn 18, Issue 3, 2000, Pages 331-337

  Roujeau, Jean Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BCG VACCINE; BROMINE; CORTICOSTEROID; COTRIMOXAZOLE; FUROSEMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDRALAZINE; IODINE; ISOTRETINOIN; METHOTREXATE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; PNEUMOCOCCUS VACCINE; RETINOIC ACID;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; CLINICAL FEATURE; DRUG ERUPTION; FEVER; HIDRADENITIS; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; PUSTULAR PSORIASIS; PUSTULOSIS; PYODERMA GANGRENOSUM; RASH; REVIEW; SUBCORNEAL PUSTULAR DERMATOSIS; TOXIC EPIDERMAL NECROLYSIS;

DRUG ERUPTIONS; HUMANS; NEUTROPHILS; PYODERMA GANGRENOSUM; SKIN DISEASES, VESICULOBULLOUS; SWEET'S SYNDROME;

EID: 0034612150     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00124-8     Document Type: Review

References (67)

1. Su W.P.D., Liu H.N.H. Diagnostic criteria for Sweet's syndrome. Cutis. 37:1986;167-174.
2. Fett D.L., Gibson L.E., Su W.P.D. Sweet's syndrome Systemic signs and symptoms and associated disorders. Mayo Clin Proc. 70:1995;234-240.
3. Homel L., Harms M., Saurat J.-H. The incidence of Sweet's syndrome in Geneva A retrospective study of 29 cases. Dermatology. 187:1993;303-305.
4. Walker D.C., Cohen P.R. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis Case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol. 34:1996;918-923.
5. Shimuzu T., Yoshida I., Eguchi H., et al. Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol. 18:1996;282-284.
6. Hasegawa M., Sato S., Nakada M., et al. Sweet's syndrome associated with granulocyte colony-stimulating factor. Eur J Dermatol. 8:1998;503-505.
7. Gilmour E., Chalmers R.J.G., Rowland D.J. Drug-induced Sweet's syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine. Br J Dermatol. 133:1995;490-491.
8. Jain K.K. Sweet's syndrome associated with granulocyte colony-stimulating factor. Cutis. 57:1996;107-110.
9. Piette W.W., Trapp J.F., O'Donnell M.J., et al. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol. 30:1994;293-297.
10. Johnson M.L., Grimwood R.E. Leucocyte colony-stimulating factors A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol. 130:1994;77-81.
11. Petit T., Francès C., Marinho E., et al. Lymphoedema-area-restricted Sweet syndrome during G-CSF treatment. Lancet. 347:1996;690.
12. Berger T.G., Dhar A., McCalmont T.H. Neutrophilic dermatoses in HIV infection. J Am Acad Dermatol. 31:1994;1045-1047.
13. Haim S., Friedman-Birnbaum R. Pyoderma gangrenosum in immunosuppressed patients. Dermatologica. 153:1976;44-48.
14. Peterson L.L. Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers. J Am Acad Dermatol. 10:1984;379-384.
15. Hughes B.R., Cunliffe W.J. Development of folliculitis and pyoderma gangrenosum in association with abdominal pain in a patient following treatment with isotretinoin. Br J Dermatol. 122:1990;683-687.
16. Gangaram H.B., Tan L.P., Gan A.T., et al. Pyoderma gangrenosum following treatment with isotretinoin. Br J Dermatol. 136:1997;636-637.
17. Lauret P., Godin M., Bravard P. Vegetating iodides after an intravenous pyelogram. Dermatologica. 171:1985;463-468.
18. Soria C., Allegue F., Espana A., et al. Vegetating iododerma with underlying systemic diseases Report of three cases. J Am Acad Dermatol. 22:1990;418-422.
19. Chang M.W., Miner J.E., Moïn A., et al. Iododerma after computed tomographic scan with intravenous radiopaque contrast media. J Am Acad Dermatol. 36:1997;1014-1016.
20. Ricci C., Krasovec M., Frenk E. Iodides à l'amiodarone traitées par ciclosporine. Ann Dermatol Venereol. 124:1997;260-263.
21. Baker H., Ryan T.J. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol. 80:1968;771-793.
22. Beylot C., Bioulac P., Doutre M.S. Pustuloses exanthématiques aïgues généralisées. A propos de 4 cas. Ann Dermatol Venereol. 107:1980;37-48.
23. Roujeau J.C., Bioulac-Sage P., Bourseau C., et al. Acute generalized exanthematous pustulosis Analysis of 63 cases. Arch Dermatol. 127:1991;1333-1338.
24. MacMillan A.L. Generalized pustular drug rash. Dermatologica. 146:1973;285-291.
25. Ogino A., Tagami H., Takahashi C., et al. Generalized pustular toxic erythema Pathogenic relationship between pustule and epidermal appendage, hair follicle or sweat gland. Acta Derm Venereol (Stockh). 58:1978;257-261.
26. Röckl H. Medikamentenallergishe vasculitis leucocytoclastica unter dem bild eines generalisierten pustulösen exanthems. Hautartz. 32:1981;467-470.
27. Staughton R.C.D., Rowland-Payne C.M.E., Harper J.I., et al. Toxic pustuloderma. A new entity. J R Soc Med. 77:(Suppl 4):1984;6-8.
28. Beylot C., Doutre M.S., Beylot-Barry M. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg. 21:1996;293-295.
29. Kint A., Geerts M.L., de Weert J. Le syndrome de Lyell. Dermatologica. 163:1981;433-454.
30. Sneddon I.B., Wilkinson D.S. Subcorneal pustular dermatosis. Br J Dermatol. 100:1979;61-68.
31. Strutton G., Weedon D., Robertson I. Pustular vasculitis of the hands. J Am Acad Dermatol. 32:1995;192-198.
32. Shear N.H., Spielberg S.P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest. 82:1988;1826-1832.
33. Bocquet H., Bagot M., Roujeau J.-C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug rash with eosinophilia and systemic symptoms-DRESS). Semin Cutan Med Surg. 15:1996;250-257.
34. Rouchouse B., Bonnefoy M., Pallot B., et al. Acute generalized exanthematous pustular dermatitis and viral infection. Dermatologica. 173:1986;180-184.
35. Naides S.J., Piette W., Veach L.A., et al. Human parvovirus B19-induced vesiculopustular skin eruption. Am J Med. 84:1988;968-972.
36. Derancourt C., Salmon-Ehr V., Perceau G., et al. Pustulose exanthématique aigüe généralisée révélatrice d'une primo-infection sévère à parvovirus B19. Ann Dermatol Venereol. 125:1998;S123.
37. Delavierre C., Milpied B., Bureau B., et al. Les pustuloses exanthématiques aïgues généralisées À propos de 5 cas. Semin Hop Paris. 64:1988;365-367.
38. Shuttleworth D. A localized, recurrent pustular eruption following amoxycillin administration. Clin Exp Dermatol. 14:1989;367-368.
39. Bernard P., Fayol J., Bonnafoux A., et al. Toxidermies aprés prise orale de pristinamycine. Ann Dermatol Venereol. 115:1988;63-66.
40. Bernard P., Amici J.M., Catanzano G., et al. Toxidermie pustuleuse aigüe généralisée, à propos d'un cas induit par la josamycine. Ann Dermatol Venereol. 116:1989;31-33.
41. Trevisi P., Patrizi A., Neri I., et al. Toxic pustuloderma associated with azithromycin. Clin Exp Dermatol. 19:1994;280-281.
42. Kalb R.E., Grossman M.E. Pustular eruption following administration of cephadrine. Cutis. 38:1986;58-60.
43. Stough D., Guin J.D., Baker G.F., et al. Pustular eruptions following administration of cefazolin A possible interaction with methyldopa. J Am Acad Dermatol. 16:1987;1051-1052.
44. Fayol J., Bernard P., Bonnetblanc J.M. Pustular eruption following administration of cefazolin A second case report. J Am Acad Dermatol. 19:1988;571.
45. Jackson H., Vion B., Levy P.M. Generalized eruptive pustular drug rash due to cephalexin. Dermatologica. 177:1988;292-294.
46. Escallier F., Dalac S., Foucher J.L., et al. Pustulose exanthématique aigue généralisée, imputabilité à l'imipènéme (Tienam®). Ann Dermatol Venereol. 116:1989;407-409.
47. Shelley E.D., Shelley W.B. The subcorneal pustular drug eruption An example induced by norfloxacin. Cutis. 42:1988;24-27.
48. Sanchez-Vizcaino J., Haro Gabaldon V., Galvez Moreno M., et al. Pustulosis exantematica generalizada aguda A proposito de dos casos inducidos por diltiazem y ciprofloxacin. Actas Dermo Sif. 85:1995;243-245.
49. Yamasaki R., Yamasaki M., Kawasaki Y., et al. Generalized pustular dermatosis caused by isoniazid. Br J Dermatol. 112:1985;504-506.
50. Yamamoto T., Minatohara K. Minocycline-induced acute generalized exanthematous pustulosis in a patient with generalized pustular psoriasis showing elevated level of sELAM1. Acta Derm Venereol. 77:1997;168-169.
51. Trueb R.M., Burg G. Acute generalized exanthematous pustulosis due to doxycycline. Dermatology. 186:1993;75-78.
52. MacDonald K.J.S., Green C.M., Kenicer K.J.A. Pustular dermatosis induced by co-trimoxazole. BMJ. 293:1986;1279-1280.
53. Friedman S.J. Pustular psoriasis associated with hydroxychloroquine. J Am Acad Dermatol. 16:1987;1256-1257.
54. Janier M., Froidevaux D., Lons-Danic D., et al. Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil. Dermatology. 196:1998;271.
55. Dupin N., Gorin I., Djien V., et al. Acute generalized exanthematous pustulosis induced by terbinafine. Arch Dermatol. 132:1996;1253-1254.
56. Kempinaire A., De Raeve L., Merckx M., et al. Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result. J Am Acad Dermatol. 37:1997;653-655.
57. Rosenberger A., Tebbe B., Treudler R., et al. Acute generalized exanthematous pustulosis induced by nystatin. Hautartz. 49:1998;492-495.
58. Aquilina C., Viraben R., Roueire A. Acute generalized exanthematous pustulosis A cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor. Arch Intern Med. 158:1998;2160-2161.
59. De Coninck A.L., Van Srubarq A.S., Pipeleers-Marichal M.A., et al. Acute generalized exanthematous pustulosis induced by paracetamol. Dermatology. 193:1996;338-341.
60. Leger F., Machet L., Jan V., et al. Acute generalized exanthematous pustulosis associated with paracetamol. Acta Derm Venereol. 78:1998;222-223.
61. Commens C.A., Fischer G.O. Toxic pustuloderma following carbamazepine therapy. Arch Dermatol. 124:1988;178-179.
62. Lambert D.G., Dalac S., Beer F., et al. Acute generalized exanthematous pustular dermatitis induced by diltiazem. Br J Dermatol. 118:1988;308-309.
63. Jan V., Machet L., Gironet N., et al. Acute generalized exanthematous pustulosis induced by diltiazem Value of patch testing. Dermatology. 197:1998;274-275.
64. Demitsu T., Kosuga A., Yamada T., et al. Acute generalized exanthematous pustulosis induced by dexamethasone injection. Dermatology. 193:1996;56-58.
65. Dooms-Goossens A., Loncke J., Michiels J.L., et al. Pustular reactions to hexafluorosilicate in foam rubber. Contact Dermatitis. 12:1985;42-47.
66. Bernard P., Lizeaux-Parneix V., Miossec V., et al. HLA et prédisposition génétique dans les pustuloses exanthématiques aiguës généralisées (PEAG) et dans les exxanthèmes maculo-papuleux (EMP). Ann Dermatol Venereol. 122:1995;S38-S39.
67. Wolkenstein P., Chosidow O., Fléchet M.L., et al. Patch-testing in severe cutaneous adverse drug reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis. 35:1996;234-236.